temozolomide has been researched along with bay 11-7082 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Akay, M; Akay, YM; Avci, NG; Ebrahimzadeh-Pustchi, S; Esquenazi, Y; Tandon, N; Zhu, JJ | 1 |
Akay, M; Akay, YM; Avci, NG; Pustchi, SE | 1 |
2 other study(ies) available for temozolomide and bay 11-7082
Article | Year |
---|---|
NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways.
Topics: Actin Cytoskeleton; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Glioblastoma; Humans; Immunoblotting; NF-kappa B; Nitriles; Signal Transduction; Sulfones; Temozolomide; Transcription Factor RelA | 2020 |
Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082.
Topics: Antineoplastic Agents, Alkylating; Astrocytes; Cell Line, Tumor; Cell Survival; Coculture Techniques; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Humans; Models, Biological; Neuroglia; Nitriles; Primary Cell Culture; Receptor, Notch1; Signal Transduction; Spheroids, Cellular; Sulfones; Survivin; Temozolomide; Tumor Microenvironment; Vimentin | 2020 |